Can Hyperbaric Oxygen Therapy Help Long Covid?

Long Covid has left millions of people searching for something that actually helps. Hyperbaric oxygen therapy, or HBOT, is one of the treatments that keeps coming up. The short answer: the evidence is early, mixed, and not yet strong enough to call HBOT an established treatment for Long Covid. A small number of trials have shown some promising results, but the studies are few, often small, and sometimes reach opposite conclusions. HBOT is not a proven cure, and it is not a standard part of Long Covid care.

That does not mean the research is worthless. It means the picture is incomplete. Here is what the science actually shows, where the uncertainty sits, and why this treatment draws so much attention.

What Is Hyperbaric Oxygen Therapy?

HBOT places a person inside a pressurized chamber and has them breathe pure oxygen. The chamber raises the surrounding pressure above normal atmospheric levels, which lets the lungs take in far more oxygen than usual. That extra oxygen travels through the bloodstream and reaches tissues that may be starved of it.

The therapy is well established for a specific list of conditions. These include decompression sickness in divers, carbon monoxide poisoning, non-healing diabetic wounds, and certain serious infections involving oxygen-starved tissue. In these cases, the benefit is supported by decades of clinical use and research.

HBOT is not the same as sitting in a mild inflatable bag at a wellness spa. Real HBOT uses regulated pressures and oxygen concentrations, delivered in a medical setting. The gap between clinical HBOT and consumer “mild hyperbaric” products is large, and the two should not be confused.

Why Would HBOT Be Considered for Long Covid?

The reasoning comes from what researchers think may be driving Long Covid in some people. Several theories exist, and none is fully confirmed.

One idea involves lingering inflammation. Another points to tiny blood clots and poor blood flow in small vessels. A third suggests that oxygen delivery to tissues may be impaired. HBOT, in theory, could address some of these by increasing oxygen in the blood and possibly reducing inflammation.

Here is the important caution. A treatment making biological sense is not the same as a treatment that works. Many plausible ideas fail when tested in people. The mechanism is a reason to study HBOT, not a reason to assume it helps.

What Does the Research Actually Show?

The clinical evidence is limited, and the results do not line up neatly. Some small trials have reported improvements in symptoms like fatigue, brain fog, and sleep after HBOT. Others have found little or no meaningful difference compared with a control group.

Study size is a real problem. Many trials enrolled only a few dozen participants, which makes results easy to overstate. Small studies can show a benefit by chance, and they often do. When a treatment is tested in larger, better-controlled trials, the effect sometimes shrinks or disappears.

Another challenge is blinding. It is hard to hide from a participant whether they are in a pressurized chamber. If people know they are getting the “real” treatment, their reported symptoms can improve for reasons unrelated to oxygen. This is called a placebo effect, and it is powerful in conditions where fatigue and brain fog are measured largely by how people feel.

The honest summary: a few studies suggest possible benefit, but the evidence is not consistent or strong enough to confirm that HBOT treats Long Covid. More and larger trials are needed before that changes.

What Are the Risks and Downsides?

HBOT is not risk-free. The most common side effect is ear and sinus discomfort from pressure changes, similar to what you feel on a plane. More serious but uncommon risks include temporary vision changes, lung injury from pressure, and, rarely, seizures from too much oxygen.

There is also a risk that does not show up in a side-effect list: cost and delay. HBOT sessions are expensive, often not covered by insurance for Long Covid, and typically require many visits. Time and money spent on an unproven treatment is time and money not spent on approaches with better support.

People with certain lung conditions, ear problems, or a history of collapsed lung may not be suitable candidates. Anyone considering HBOT should discuss it with a doctor who knows their full health history, not a clinic selling the service.

Is HBOT Recommended for Long Covid?

No major clinical guideline currently recommends HBOT as a standard treatment for Long Covid. That is a key fact. Some clinicians may offer it in research settings or on a case-by-case basis, but that is different from an established recommendation.

This gap matters. When a treatment is widely marketed before the evidence catches up, patients can end up paying for something that has not been proven to help them. The absence of a recommendation is not proof that HBOT does nothing. It means the proof is not there yet.

How Does HBOT Compare With Other Long Covid Approaches?

Long Covid care generally focuses on managing symptoms and supporting recovery, since there is no single approved treatment. Approaches often include paced activity, sleep support, and treatment of specific problems like breathing issues or anxiety. These are not cures either, but they rest on more established ground.

HBOT sits in a different category. It is an active, mechanistically interesting intervention with early but inconsistent evidence. That makes it worth watching, and worth studying, but not yet worth treating as a proven option.

What Should You Do If You Are Considering HBOT?

If HBOT is something you want to explore, the safest path is through a research study or a doctor experienced with Long Covid. Ask directly whether the treatment is proven, what the evidence shows, and what it will cost. A clinic that promises a cure is a warning sign, because no treatment has been shown to cure Long Covid.

Be wary of claims that sound absolute. Phrases like “clinically proven for Long Covid” are not supported by the current evidence. If a provider cannot point to solid trials, that tells you something.

• Ask whether the treatment is part of a study or standard care.
• Ask what the realistic expected benefit is, based on evidence.
• Ask about total cost and number of sessions required.
• Ask about your personal risks given your health history.

The Bottom Line on HBOT and Long Covid

HBOT is a real medical treatment with proven uses in specific conditions. For Long Covid, the evidence is still developing. Some small studies suggest possible benefit, but results are inconsistent, studies are small, and no major guideline recommends it. That is the honest state of things right now.

This is a field that could change. If larger, well-controlled trials show clear benefit, the picture would shift. Until then, treating HBOT as a proven Long Covid remedy goes beyond what the science supports.